GLUCOSE Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose

fresenius kabi limited - glucose anhydrous - solution for infusion - 10 %w/w - carbohydrates

Glucose 5% w/v Solution for Infusion Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose 5% w/v solution for infusion

fresenius kabi limited - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates

GLUCOSE Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose

maco pharma (uk) ltd - glucose monohydrate - solution for infusion - 5 %w/v - electrolytes with carbohydrates

GLUCOSE Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose

fresenius kabi limited - glucose anhydrous - solution for infusion - 5 %w/w - carbohydrates

GLUCOSE 5% W/V INTRAVENOUS INFUSION Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose 5% w/v intravenous infusion

baxter healthcare limited - glucose monohydrate - solution for infusion - 5.0 anhyd %w/v - carbohydrates

Glucose Injection BP Minijet 50%w/v, Solution for injection Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose injection bp minijet 50%w/v, solution for injection

international medication systems (uk) ltd - anhydrous glucose - solution for injection - 50 percent weight/volume - carbohydrates; glucose

Sodium Chloride 0.45% w/v and Glucose 5.0% w/v Solution for Infusion BP Malta - angličtina - Medicines Authority

sodium chloride 0.45% w/v and glucose 5.0% w/v solution for infusion bp

baxter healthcare limited - glucose, sodium chloride - solution for infusion - glucose 5 percent weight/volume ; sodium chloride 0.45 percent weight/volume - blood substitutes and perfusion solutions

Glucose 5g/100 ml B. Braun Vet Care solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats Írsko - angličtina - HPRA (Health Products Regulatory Authority)

glucose 5g/100 ml b. braun vet care solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats

b. braun melsungen ag. - glucose monohydrate - solution for infusion - 5 grams/100 millilitres - i.v. solutions - cats, cattle, dogs, goats, horses, pigs, sheep - electrolytes

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

xelevia sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 32.13 mg (equivalent: sitagliptin, qty 25 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; sodium stearylfumarate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - xelevia (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies.

XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

xelevia sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack

merck sharp & dohme (australia) pty ltd - sitagliptin phosphate monohydrate, quantity: 64.25 mg (equivalent: sitagliptin, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; sodium stearylfumarate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - xelevia (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 pharmacodynamic properties, clinical trials, 4.5 interactions with other medicines and other forms of interactions for available data on different add-on combination therapies.